11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Drent E, Poels R, Ruiter R, van de Donk NWCJ, Zweegman S, Yuan H, de Bruijn J, Sadelain M, Lokhorst HM, Groen R, Mutis T, Themeli M. Combined CD28 and 4-1BB costimulation potentiates affinity-tuned Chimeric Antigen Receptor-engineered T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30979735 DOI: 10.1158/1078-0432.Ccr-18-2559  0.36
2016 Kotini AG, Sadelain M, Papapetrou EP. LiPS-A3S, a human genomic site for robust expression of inserted transgenes. Molecular Therapy. Nucleic Acids. 5: e394. PMID 28427140 DOI: 10.1038/mtna.2016.99  0.72
2016 Kotini AG, Sadelain M, Papapetrou EP. LiPS-A3S, a human genomic site for robust expression of inserted transgenes. Molecular Therapy. Nucleic Acids. 5: e394. PMID 28131289 DOI: 10.1038/mtna.2016.99  0.72
2016 Kotini AG, Sadelain M, Papapetrou EP. LiPS-A3S, a human genomic site for robust expression of inserted transgenes. Molecular Therapy. Nucleic Acids. 5: e394. PMID 27898090 DOI: 10.1038/Mtna.2016.99  0.72
2016 Mansilla-Soto J, Riviere I, Boulad F, Sadelain M. Cell and gene therapy for the beta-thalassemias: advances and prospects. Human Gene Therapy. PMID 27021486 DOI: 10.1089/Hum.2016.037  0.4
2016 Themeli M, Sadelain M. Combinatorial Antigen Targeting: Ideal T-Cell Sensing and Anti-Tumor Response. Trends in Molecular Medicine. PMID 26971630 DOI: 10.1016/J.Molmed.2016.02.009  0.36
2016 Kotini AG, de Stanchina E, Themeli M, Sadelain M, Papapetrou EP. Escape Mutations, Ganciclovir Resistance, and Teratoma Formation in Human iPSCs Expressing an HSVtk Suicide Gene. Molecular Therapy. Nucleic Acids. 5: e284. PMID 26836371 DOI: 10.1038/Mtna.2015.57  0.72
2015 Perna F, Vu LP, Themeli M, Kriks S, Hoya-Arias R, Khanin R, Hricik T, Mansilla-Soto J, Papapetrou EP, Levine RL, Studer L, Sadelain M, Nimer SD. The polycomb group protein L3MBTL1 represses a SMAD5-mediated hematopoietic transcriptional program in human pluripotent stem cells. Stem Cell Reports. 4: 658-69. PMID 25754204 DOI: 10.1016/J.Stemcr.2015.02.003  0.72
2014 Davila ML, Riviere I, Wang X, Bartido S, Park J, Curran K, Chung SS, Stefanski J, Borquez-Ojeda O, Olszewska M, Qu J, Wasielewska T, He Q, Fink M, Shinglot H, ... ... Sadelain M, et al. Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia. Science Translational Medicine. 6: 224ra25. PMID 24553386 DOI: 10.1126/Scitranslmed.3008226  0.4
2014 Boulad F, Wang X, Qu J, Taylor C, Ferro L, Karponi G, Bartido S, Giardina P, Heller G, Prockop SE, Maggio A, Sadelain M, Rivière I. Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation. Blood. 123: 1483-6. PMID 24429337 DOI: 10.1182/Blood-2013-06-507178  0.4
2013 Fedorov VD, Themeli M, Sadelain M. PD-1- and CTLA-4-based inhibitory chimeric antigen receptors (iCARs) divert off-target immunotherapy responses. Science Translational Medicine. 5: 215ra172. PMID 24337479 DOI: 10.1126/Scitranslmed.3006597  0.36
Show low-probability matches.